21.02.2022 • NewsCatalent

Catalent Expands China Clinical Capabilities

US CDMO Catalent plans to expand its facility in Shanghai, China, doubling capacity for the temperature-controlled storage and distribution of clinical supplies and adding secondary packaging capabilities. The expansion is expected to be completed by the middle of this year.

“We have seen great demand for clinical supply services in China. This expansion will increase both capacity and capabilities at the Shanghai facility, and makes provision for the growing trend in clinical trials of advanced therapeutics requiring specialized storage and handling capabilities, including deep-frozen for emerging biotech companies,” said Roel de Nobel, vice president and general manager, APAC, clinical supply services.

The facility in the Waigaoqiao Free Trade Zone is one of two clinical supply sites that Catalent operates in Shanghai – the other, which opened in April 2019, is located in Tangzhen. Together, said Catalent, they provide sponsors with optimized supply solutions for studies performed both in China and Asia-Pacific, as well as worldwide.

Author: Elaine Burridge, Freelance Journalist

(c) Denys Nevozhai
(c) Denys Nevozhai

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.